Amyris, Inc.
Emeryville, CA Part of Novotico Ventures, LLC
- UEI
- SHKJE1C1HEN7
- CAGE
- 47QN9
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Novotico Ventures, LLC
Parent
WHAGBFL4YML3
-
Amyris, Inc.
SHKJE1C1HEN7
- Amyris Fuels, LLC KFKTPHU8CEL4
-
Amyris, Inc.
SHKJE1C1HEN7
-
Novotico Ventures, LLC
Parent
WHAGBFL4YML3
- SAM.gov registration date
- Physical address
- 5885 Hollis St ste 100, Emeryville, CA 94608, USA
- Website
- amyris.com
- Founded
- 2003
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Materials
- Chemicals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Biosynthetic caryopholen | Naval Air Warfare Center | $253,993 | |
| Integrated process for commercial production of farnesene from domestic lignocellulosic feedstock | Office of Energy Efficiency and Renewable Energy | $5,447,456 | |
| The purpose of this modification is to increase incremental funding in the amount of 478,484 on contract… | Defense Advanced Research Projects Agency | $1,875,147 | |
| - wait, what conference purchase order | Defense Advanced Research Projects Agency | $16,227 | |
| Amyris aviation grade farnesane | Glenn Research Center | $7,500 |
About Amyris, Inc.
Amyris, Inc. is a biotechnology company that provides sustainable alternatives to petroleum sourced products using industrial synthetic biology. Through federal contract awards, Amyris has provided biosynthetic caryophyllene and other sesquiterpenes to the Department of the Navy Naval Air Systems Command Naval Air Warfare Center. Specifically, Amyris was awarded a $335,578 firm fixed price definitive contract to conduct small-scale fermentations and distill caryophyllene, humulene, or cadinene to over 95 percent purity with principal components over 90 percent.
As a subcontractor under federal grants, Amyris has produced analogues of squalene using their bioengineered yeast platform for the Access To Advanced Health Institute. These molecules were characterized before being sent to the prime grantee for formulation development and bioactivity testing. Amyris has also received subawards from the Bioindustrial Manufacturing And Design Ecosystem for various research projects related to detailed research, vaccine manufacturing, and supply chain development.
Through federal grants and contracts, Amyris leverages its biotechnology and synthetic biology capabilities to provide specialized compounds, conduct research, and participate in initiatives to strengthen domestic supply chains and manufacturing. As both a prime contractor and subrecipient of federal funding, the company performs a range of services applicable to defense, health, and industrial biotechnology.
Quick answers
What is Amyris, Inc.'s UEI?
Amyris, Inc.'s Unique Entity ID (UEI) in SAM.gov is SHKJE1C1HEN7.
What is Amyris, Inc.'s CAGE code?
Amyris, Inc.'s CAGE code is 47QN9.
What is Amyris, Inc.'s primary NAICS code?
Amyris, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Amyris, Inc. located?
Amyris, Inc.'s physical address in SAM.gov is 5885 Hollis St ste 100, Emeryville, CA 94608, USA.
Is Amyris, Inc. registered in SAM.gov?
Yes. Amyris, Inc.'s SAM.gov registration is active through April 27, 2027.
Who is Amyris, Inc.'s parent company?
Amyris, Inc. is part of Novotico Ventures, LLC.
What is Amyris, Inc.'s most recent federal award?
Amyris, Inc.'s most recent federal contract award is Biosynthetic caryopholen (N6893622C0040), from Naval Air Warfare Center, on September 30, 2022.
On GovTribe
See Amyris, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors